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AgrEvo is a German producer of crop protection products.  In 1995 it made the strategic 
decision to shift from crop protection to crop production, with the help of biotechnology. 
It acquired Plant Genetic Systems (PGS), a successful plant biotechnology company, and 
started a round of acquisitions in the international seed industry.  The company soon 
found out that biotechnology brings many new uncertainties in strategic decision-making. 
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Hoechst Schering AgrEvo GmbH (or AgrEvo) was a German manufacturer of chemicals for 
crop protection until 1995. Its main products were herbicides, insecticides, and fungicides, used in
the production of all major field crops as well as for fruits and vegetables. AgrEvo also produced 
pesticides for non-agricultural uses, particularly to control insects in human environments. In 
addition, the company was selling seeds, both for horticultural and agricultural crops. For maize, 
canola, and soybeans, AgrEvo had developed genetically modified varieties. 
 
The central element in AgrEvo’s strategy was to transition from a crop protection to crop 
production company. AgrEvo no longer just wanted o sell pesticides but also to become a 
provider of productivity enhancing solutions to the farmer.  Biotechnology was seen as the major 
element in this strategic reorientation, as the focus of crop protection shifted from the chemical 
molecule to the genetic constitution of the plant itself. Expanding into the seed business was a 
necessary step in the implementation of this long term strategy. 
 
As an independent company, AgrEvo has only existed for 5 years. It was established in 1994 
when two German producers of chemicals and pharmaceuticals, Hoechst and Schering, merged 
their crop protection divisions into a new joint venture. Both companies wanted to benefit from 
economies of scale in marketing and research and development (R&D). In 1999, AgrEvo’s 
majority shareholder, Hoechst, merged with the French pharmaceutical and chemical company 
Rhône-Poulenc to become Aventis. As a result, AgrEvo and Rhône-Poulenc Agro have been 
combined into Aventis CropScience. This article presents an analysis of AgrEvo before the 
merger. 
 
Main Products And Markets  
 
In 1999, AgrEvo was the fourth largest producer of crop protection products, after Novartis, 
Monsanto, and Zeneca. In the European market, AgrEvo was the second largest supplier of 
pesticides, with a market share of approximately 12 percent. In 1998, AgrEvo had a turnover of 
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2.1 billion Euro (table 1). The company invested 247 million Euro in R&D, which is about 12 
percent of sales. 
 
Table 1:  Key Figures (Million Euro). 
 
 1994 1995 1996 1997 1998 
Net Sales 1,658.5 1,679.0 1,819.5 2,034.5 2,121.5 
Operating Profit 17.0 84.0 97.0 157.0 176.5 
Cash Flow N/A 94.0 217.0 253.5 145.5 
R&D Costs 209.0 194.0 217.0 255.5 247.5 
Investments In Fixed Assets 49.0 53.5 71.5 118.5 65.5 
Employment N/A 7,459 7,427 8,550 8,658 
Note. N/A= Not Available. From “AgrEvo 1997 Annual Report,” by AgrEvo, 1997. Berlin, 
Germany: AgrEvo; and “AgrEvo 1998 Annual Report,” by AgrEvo, 1998. Berlin, Germany: 
AgrEvo.  
 
Herbicides were AgrEvo’s main product, representing 42 percent of turnover (table 2). AgrEvo 
had a share of 8 percent in the world herbicide market. Forty percent of AgrEvo’s herbicide 
production was sold in Europe. For sugar beet and cereal herbicides the company was the market 
leader in Europe. AgrEvo was particularly strong in grass-herbicides for cereals, with products 
like Puma/Excel and Illoxan. For sugar beet, the main herbicide sold was Betanal. 
 
 
Table 2:  Sales by Main Product Group (1998). 
 
Products Million Euro Percentage of Total 
Herbicides   880.5 42 
Insecticides   454.0 21 
Fungicides   341.0 16 
Environmental Health   194.5   9 
Seeds/Crop Improvement   119.0   6 
Others   132.5   6 
Total 2,121.5 100 
Note. From “AgrEvo 1997 Annual Report,” by AgrEvo, 1997. Berlin, Germany: AgrEvo; and 
“AgrEvo 1998 Annual Report,” by AgrEvo, 1998. Berlin, Germany: AgrEvo.   
 
A very important herbicide for AgrEvo’s biotechnology ambitions was Liberty. This product was 
a new formulation of the non-selective herbicide glufosinate, that AgrEvo and Hoechst had been 
selling under various brand names since 1984 (e.g., Basta, Ignite, Finale and Challenge). The old 
glufosinate products were particularly used on fruit and vegetable crops, but Liberty can be used 
on transgenic field crops, thus, greatly expanding its potential market. 
 
Seeds/Crop Improvement was the biotechnology and seeds business of AgrEvo. This product 
group was newly formed in 1997, after the acquisition of Plant Genetic Systems and the shift of 
Nunhems Seeds from parent company Hoechst to AgrEvo. Although this business activity 
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accounted for only a small percentage of AgrEvo’s turnover, it was considered the main strategic 





AgrEvo’s innovation strategy can be summarized by the following statement by Dr. G. Prante, 
AgrEvo’s Chief Executive Officer (CEO), 
 
We have taken the strategic decision to develop from a plant protection enterprise 
to a company offering farmers products for enhancing the productivi y of plant 
production through innovations in chemistry, biotechnology and plant breeding. 
(Bijman & Bogaardt, 2000, p.11)
 
From the early 1980s, when the first results of biotechnology research become known and a bright 
future for this new key technology was forecasted, Hoechst has been active in this type of 
research. As a pharmaceutical company, it heavily invested in biotechnology R&D, particularly in 
the United States (US). As a major producer of agrochemicals, research on plant biotechnology 
was only a small step to make. Hoechst had both in-house research and research contracts with 
small biotechnology companies. For instance, research on glufosinate-tolerance was contracted at 
PGS. 
 
The importance of seeds for the biotechnology business was already acknowledged in the 1980s. 
In 1985, Hoechst took a minority share in, and started research collaboration with, KWS—the 
largest German agricultural seed company. In 1986 Hoechst had acquired Nunhems Seeds, a 
Dutch vegetables seed company. 
 
In 1995 AgrEvo tok the strategic decision to become a serious player in the global plant 
biotechnology industry. Several developments led to this decision. First, Hoechst had built up 
biotechnology expertise and saw good commercial prospects. Second, the market prospects for 
agrochemicals, particularly in Europe and North America, were not very promising. Third, major 
competitors, particularly Monsanto and Novartis, were all heavily investing in biotechnology and 
seeds. Fourth, the herbicide-resistance technology developed by PGS for Hoechst/AgrEvo’s 
broad-spectrum herbicide glufosinate was ready for commercialization. Therefore, AgrEvo 
decided to expand not only in biotechnology but also in seeds as it acknowledged that for 
commercialization of biotechnology products access o seeds was indispensable. 
 
The 1996 acquisition of PGS (for 436 million Euro) was a major step in implementing the new 
strategy. Plant Genetic Systems brought to AgrEvo extensive knowledge of plant biotechnology 
as well as plant breeding. Plant Genetic Systems was one of the most successful dedicated 
biotechnology firms. It was already established in 1982 by a group of researchers from the 
University of Gent, Belgium. These scientists were among the first in the world in 1983 to 
develop a genetically modified plant. Based on its expertise in genetic engineering, PGS had built 
up a very good intellectual property position. By cross-licensing patents and genes, PGS also had 
broad, low-cost access to other biotechnologies. Plant Genetic Systems’ biotechnology research 
has been focused on three main application areas: weed control, insect control, a d hybrid 
breeding. The resulting products are named LibertyLink, StarLink and SeedLink, respectively. 
 
LibertyLink refers to crops with genetically engineered glufosinate tolerance. The first 
LibertyLink canola varieties were introduced by PGS in Canada in 1995. In 1997, LibertyLink 
maize varieties were introduced in the US. AgrEvo does not have its own maize breeding program 
in North America, but uses alliances with all major maize seed companies. In Europe, AgrEvo has 
several LibertyLink crop varieties approved under Directive 90/220, particularly oilseed rape and 
maize, while others are pending approval. Importation of grain derived from LibertyLink maize 
was aproved by the European Union in 1998. 
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Starlink refers to genetically engineered crops which produce their own insecticide (Bac llus 
thuringiensis crystal protein). Starlink maize has been grown in the US since 1999.  AgrEvo only 
provides the technology which local seed companies incorporate in their varieties.  Since 2000 
Starlink maize has been withdrawn from the US market. 
 
SeedLink refers to hybrid seeds obtained by genetic engineering. For the commercialization of its 
hybridization technology, PGS had decided to start its own breeding program for canola in 
Canada. No hybrid canola existed, while research had shown that substantial yield enhancements 
were possible by planting hybrid varieties instead of conventional varieties. Since 1997, SeedLink 
canola hybrids have been grown by farmers in Canada and the United States.  
 
Expansion In Seeds 
 
By taking over PGS, AgrEvo acquired its own seed business for field crops. This was the 
beginning of a rapid expansion in the seed industry, in order to gain access to elite germplasm for 
incorporation of its technology. In the words of an AgrEvo manager, “You have to have an 
envelope to send your post.”  A plant biotechnology company that wants to commercialize its 
proprietary technology and genes can potentially follow three paths: it can set up a new breeding 
program (as PGS did for canola); it can contract with seed companies; and it can take over seed 
companies. AgrEvo is following all three routes, depending on the exigencies of the crops and the 
particular market situation. 
 
For example, in 1997 AgrEvo established an international cotton seed joint venture with Cotton 
Seed International (CSI) of Wee Waa, Australia. The new company, called AgrEvo Cotton Seeds 
International (ACSI), is based in Memphis, Tennessee, US.  AgrEvo owns 51 percent of ACSI, 
and CSI owns 49%. ACSI develops cotton varieties for the US and other markets.  
 
In 1998, AgrEvo wanted to acquire the American seed company Cargill Hybrid Seeds North 
America (for $US 650 million).1  By acquiring Cargill, AgrEvo would have obtained direct access 
to the North American corn market. However, due to a legal dispute between Cargill and Pioneer 
Hi-Bred International about infringement of patents, the acquisition was cancelled. 
 
Also in 1998, AgrEvo acquired the rice breeding program and associated assets of the Brazilian 
seed company Granja 4 Irmaos. Granja was the leading producer and supplier of rice seeds in 
Brazil at the time, while its affiliated company, Josapar, was the country’s largest rice grain 
retailer. Granja was developing hybrid rice in collaboration with the French national research 
institute CIRAD. 
 
In 1999, AgrEvo acquired the Indian Proagro Group of companies which comprised Proagro Seed 
Company Ltd., Proagro-PGS India Ltd., Hybrid Rice Interna io al, and MISR Hytech. The 
Proagro Group was the second largest seed company in India, ranking number one in hybrid corn, 
millet, and forage sorghum, and second in sunflower and grain sorghum. The Proagro Group was 
also developing hybrid rice, cotton, oilseed rape, and vegetables for India and other
markets in Asia, the Middle East, and North Africa. 
 
This same year, AgrEvo acquired the Brazilian seed companies Sementes Ribeiral and Sementes 
Fartura, as well as the corn research company Mitla Pesquisa Agricola. Ribeiral and Fartura were 
formed in 1973 and 1976, respectively. Mitla was formed in 1993 as the joint corn research 
company of Ribeiral and Fartura. Mitla was a foundation corn seed company engaged in the 
breeding and development of proprietary con parent lines. The combined turnover of the three 
companies in 1998 was approximately US$9 million. Together the companies accounted for 
approximately 8% of the Brazilian hybrid corn seed market. They also produced soybean and 
sorghum seed for the Brazilian market. 
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AgrEvo has also expanded in vegetable crops. In 1997, Nunhems Seeds was shifted from the 
parent company Hoechst to AgrEvo, and AgrEvo acquired the American company Sunseeds 
Corporation. Sunseeds produced hybrid vegetable seeds and had 300 employees worldwide. It had 
a fully owned subsidiary in India and joint ventures in China and Chile. It occupied a leading 
market position in the field of carrots and onions in the US.  It also sold seeds for fresh and 
processed tomatoes, melon, watermelon, and cucumber. Nunhems and Sunseeds became the two 
business units of the holding company Nunza. In 1998, Nunza acquired Leen de Mos, a Dutch 
vegetable seed company, strengthening its market position in seed sales for cucumber and lettuce. 
In India, Sunseeds India was integrated with Proagro-PGS to create a single joint venture—
Nunhems-Proagro. With the 1999 acquisition of Proagro by AgrEvo, the company was fully 
integrated in Nunza. Also in 1999, Nunza acquired Rio Colorado Seeds, located in California 
which specializes in hybrid onion seeds. In 1998, Nunza was number four in the worldwide 
vegetable seeds market, with approximately 900 employees, of which 275 are located at Nunhems 
in the Netherlands. 
 
Living In A Different World 
 
The strategic transition from c p protection to crop production brought major changes for the 
organization and decision making within AgrEvo and brought new challenges for its relationship 
with various stakeholders. Although the company had only been formed in 1994, its constituent 
parts had a long tradition in developing, producing, and marketing crop protection products. 
Decision making on new pesticides was routine, the company knew which tests to do and what 
information to provide to regulators. Legal requirements were clear and similar all over the world. 
While government policies to protect human, animal, and environmental health resulted in ever 
stricter requirements for new pesticides, and thus higher R&D and registration costs, AgrEvo 
managers considered this trend as predictable. They anticipated future developments in 
government regulation of the pesticide market, and installed strict go/no-go decisions early in the 
product development process. 
 
On the biotechnology side, the learning curve on how to deal with regulation has be n much 
steeper. The rapid strategic shift to become a plant biotechnology company brought different 
types of uncertainty to AgrEvo decision makers, “different requirements in different countries, 
low transparency of the (political) decision making process, adding new requirements all the time, 
approval at one level of regulation and prohibition at another, etc.” (Bijman & Bogaardt, 2000, 
p.18). These uncertainties made decision-making on biotechnology innovation extremely difficult. 
 
In 1989, Plant Genetic Systems had its first field trials with genetically modified plants in France, 
the US, and Canada. Particularly among farmers did PGS not see a different attitude between 
Europe and North America. But the regulation that was decided upon for these field trials, and for 
further introduction of genetically modified organisms (GMOs), turned out to be very different on 
both sides of the Atlantic. In America there is the so-called deregulation since 1993—once a 
product is considered safe, further activities wih this product do not have to be approved, and 
labeling and segregation is not needed. AgrEvo favors this type of regulation because it looks at 
the product and not the technology. In Europe, on the other hand, a GMO remains a GMO even 
when it is approved. This leads to the demand for labeling and for repetitive approvals for 
products derived from the GMO crop. These differences in the type of regulation between Europe 
and North America have made it very difficult for AgrEvo to decide what products to develop. 
Because of international trade in agricultural products, the European regulation on approval, 
labeling, thresholds, and segregation (or the absence of definite regulation) has even influenced 
AgrEvo’s innovation activities in the North American market. 
 
One of the organizational effects of focusing on biotechnology and the introduction of genetically 
modified crops has been the strengthening of central decision-m king. Because the main 
agricultural crops are traded internationally, decisions about the marketing of transgenic crop 
varieties have to take into account the regulatory affairs concerning biotechnology in other 
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countries. Local decisions on crops can have global repercussions. Even when a product is not 
exported, the influence of pressure groups campaigning against biotechnology encourages 
AgrEvo to take a global perspective in deciding whether to market a transgenic crop. Thus, the 
worldwide debate on the merits of biotechnology, and the activism of globally operating non-
governmental organizations (NGOs) like Greenpeace, have even shifted marketing decisions from 
the local and regional affiliates back to headquarters in Frankfurt. This re-cent alization of 




AgrEvo’s strategic reorientation from crop protection to crop production seems a logical one from 
a technological point of view. Biotechnology has opened up new opportunities to shift crop 
protection from chemicals back to genetics and to new combinations of the two. However, 
biotechnology has also brought many new uncertainties to the company. While the success of a 
new pesticide basically depends on two criteria, governmental approval and farmer uptake, the 
success of a genetically modified crop variety is contingent upon the formal or informal approval 
of a large range of stakeholders. Different regulatory requirements in different parts of the world 
have to be complied with, various national and international NGO’s have to be pleased, and all 
firms in the agrifood production and distribution chain have to give their consent. While farmers 
may be the primary clients of AgrEvo’s products, whether they will grow transgenic varieties is 
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